The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis?A Meta-Analysis

Background: The expression of noncoding RNAs (ncRNAs) is closely related to breast cancer progression. However, there is no systemic analysis of ncRNAs in breast cancer diagnosis of the blood circulatory system. Herein, we aimed to collect all the evidence to test the potential role of ncRNAs as no...

Full description

Bibliographic Details
Main Authors: Miao Wang, Guohui Li, Ranru Wei, Zhaojun Jia, Yao Gu, Aman Sattout, Jie Zhang, Feng Zhao
Format: Article
Language:English
Published: Mary Ann Liebert 2021-01-01
Series:Re:GEN Open
Subjects:
Online Access:https://www.liebertpub.com/doi/full/10.1089/REGEN.2021.0014
_version_ 1827374042344062976
author Miao Wang
Guohui Li
Ranru Wei
Zhaojun Jia
Yao Gu
Aman Sattout
Jie Zhang
Feng Zhao
author_facet Miao Wang
Guohui Li
Ranru Wei
Zhaojun Jia
Yao Gu
Aman Sattout
Jie Zhang
Feng Zhao
author_sort Miao Wang
collection DOAJ
description Background: The expression of noncoding RNAs (ncRNAs) is closely related to breast cancer progression. However, there is no systemic analysis of ncRNAs in breast cancer diagnosis of the blood circulatory system. Herein, we aimed to collect all the evidence to test the potential role of ncRNAs as novel biomarkers in human breast cancers. Methods: We used a comprehensive search strategy to search relevant literature in the Web of Science, PubMed, and Embase databases from January 2012 to April 2021. The correlation of ncRNAs expression in serum, plasma, or blood circulatory system and the diagnostic accuracy of breast cancer (BC) markers were analyzed. We assessed the methodological quality of each study using the Quality Assessment of Diagnostic Accuracy Studies-2. Statistical analysis was performed using the STATA (version 12.0), Meta-Disc (version 1.4), and Review Manager (version 5.3) software. Results: This study analyzes the ncRNAs expression data of BC patients and healthy specimens? blood from 2,120 patients in 29 publications (40 studies). The pooled sensitivity, specificity, and area under the curve (AUC) values were 0.81, 0.83, and 0.89, respectively. Subgroup analyses showed that the expression of ncRNA (micro RNA [miRNA], circular RNAs [circRNA], and long noncoding RNAs [lncRNA]) in the blood circulatory system (blood, plasma, and serum) of BC was more prone to be detected in miRNA group and subtype of BC (human epidermal growth factor receptor 2 [HER2]) group, with a high value of the sensitivity and AUC. Conclusions: The blood circulatory system (blood, plasma, and serum) of miRNAs, circRNAs, and lncRNAs detection may be useful for diagnosing breast cancer, particularly in the miRNA group and HER2 of breast cancer. Further studies are needed to identify the value of these ncRNAs as novel markers in clinical.
first_indexed 2024-03-08T11:26:45Z
format Article
id doaj.art-5c03017c75f444a283e5800effbc845f
institution Directory Open Access Journal
issn 2766-2705
language English
last_indexed 2024-03-08T11:26:45Z
publishDate 2021-01-01
publisher Mary Ann Liebert
record_format Article
series Re:GEN Open
spelling doaj.art-5c03017c75f444a283e5800effbc845f2024-01-26T05:11:36ZengMary Ann LiebertRe:GEN Open2766-27052021-01-01119510910.1089/REGEN.2021.0014The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis?A Meta-AnalysisMiao Wang0Guohui Li1Ranru Wei2Zhaojun Jia3Yao Gu4Aman Sattout5Jie Zhang6Feng Zhao7School of Bioengineering, Dalian University of TechnologySchool of Bioengineering, Dalian University of TechnologySchool of Bioengineering, Dalian University of TechnologySchool of Chemical Engineering, Beijing Key Laboratory of Enze Biomass Fine Chemicals, Beijing Institute of Petrochemical TechnologySchool of Bioengineering, Dalian University of TechnologySchool of Bioengineering, Dalian University of TechnologySchool of Bioengineering, Dalian University of TechnologyDepartment of Cell Biology, College of Basic Medical Sciences, Dalian Medical University Background: The expression of noncoding RNAs (ncRNAs) is closely related to breast cancer progression. However, there is no systemic analysis of ncRNAs in breast cancer diagnosis of the blood circulatory system. Herein, we aimed to collect all the evidence to test the potential role of ncRNAs as novel biomarkers in human breast cancers. Methods: We used a comprehensive search strategy to search relevant literature in the Web of Science, PubMed, and Embase databases from January 2012 to April 2021. The correlation of ncRNAs expression in serum, plasma, or blood circulatory system and the diagnostic accuracy of breast cancer (BC) markers were analyzed. We assessed the methodological quality of each study using the Quality Assessment of Diagnostic Accuracy Studies-2. Statistical analysis was performed using the STATA (version 12.0), Meta-Disc (version 1.4), and Review Manager (version 5.3) software. Results: This study analyzes the ncRNAs expression data of BC patients and healthy specimens? blood from 2,120 patients in 29 publications (40 studies). The pooled sensitivity, specificity, and area under the curve (AUC) values were 0.81, 0.83, and 0.89, respectively. Subgroup analyses showed that the expression of ncRNA (micro RNA [miRNA], circular RNAs [circRNA], and long noncoding RNAs [lncRNA]) in the blood circulatory system (blood, plasma, and serum) of BC was more prone to be detected in miRNA group and subtype of BC (human epidermal growth factor receptor 2 [HER2]) group, with a high value of the sensitivity and AUC. Conclusions: The blood circulatory system (blood, plasma, and serum) of miRNAs, circRNAs, and lncRNAs detection may be useful for diagnosing breast cancer, particularly in the miRNA group and HER2 of breast cancer. Further studies are needed to identify the value of these ncRNAs as novel markers in clinical.https://www.liebertpub.com/doi/full/10.1089/REGEN.2021.0014Noncoding RNAbreast cancerdiagnosis
spellingShingle Miao Wang
Guohui Li
Ranru Wei
Zhaojun Jia
Yao Gu
Aman Sattout
Jie Zhang
Feng Zhao
The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis?A Meta-Analysis
Re:GEN Open
Noncoding RNA
breast cancer
diagnosis
title The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis?A Meta-Analysis
title_full The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis?A Meta-Analysis
title_fullStr The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis?A Meta-Analysis
title_full_unstemmed The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis?A Meta-Analysis
title_short The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis?A Meta-Analysis
title_sort circulating level of noncoding rna for breast cancer diagnosis a meta analysis
topic Noncoding RNA
breast cancer
diagnosis
url https://www.liebertpub.com/doi/full/10.1089/REGEN.2021.0014
work_keys_str_mv AT miaowang thecirculatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT guohuili thecirculatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT ranruwei thecirculatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT zhaojunjia thecirculatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT yaogu thecirculatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT amansattout thecirculatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT jiezhang thecirculatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT fengzhao thecirculatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT miaowang circulatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT guohuili circulatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT ranruwei circulatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT zhaojunjia circulatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT yaogu circulatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT amansattout circulatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT jiezhang circulatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis
AT fengzhao circulatinglevelofnoncodingrnaforbreastcancerdiagnosisametaanalysis